ADC - Agree Realty Corporation
A stock-only portfolio paying over $12,000 a month sounds like a retirement dream, but the income splits into layers with very different levels of reliability. Before you build it, you need to know which part of that yield is real and which part is just your own money coming back to you.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
More than half of Americans fear outliving their savings, and the usual advice to "just invest" ignores the mismatch between quarterly payouts and monthly bills.
A $500,000 portfolio of high-yield REITs and BDCs can quietly hand five figures every year straight to the IRS, and the account type you choose determines whether that loss compounds against you for decades.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Some dividends are backed by nothing more than last quarter's earnings, but a handful of companies collect rent, regulated utility bills, and trash pickup fees under contracts that make next year's cash flow visible before the year even begins.
$86.6 Million Private Placement announced, with participation from new and existing investors, extending expected cash runway into 2029 HealthCare Royalty financing agreement amended, removing change-of-control payment Senior secure loan refinanced, decreasing principal to $50M with bullet payment in August 2029 and no minimum liquidity LAUSANNE, Switzerland, Oct. 8, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced a comprehensive strategic financial restructuring designed to strengthen its balance sheet, reduce leverage, and increase strategic optionality to maximize shareholder value while extending the expected cash runway into 2029. The strategic initiative includes securing new equity financing, restructuring the HealthCare Royalty (HCR) agreement, and reducing the outstanding loan principal.
Both Realty Income and Agree Realty pay monthly dividends, own net lease properties, and have pulled back sharply in recent weeks, but holding the wrong one through retirement could cost you decades of compounding growth.
Both NNN and Agree Realty cut identical deals with tenants, raised guidance the same summer, and dropped nearly the same amount in price last month, yet one of them suits a retiree's portfolio far better than the other.
Monthly dividends sound like a paycheck replacement, but the schedule is the easy part. Three REITs with October checks on the calendar reveal just how different safety, growth, and risk can look behind identical payment frequencies.
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closing of AstraZeneca's (LSE/STO/NYSE: AZN) strategic equity investment in Summit. The e
Patent discloses uses beyond ADCs, including autologous or allogeneic adoptive cellular immunotherapies like CAR-T, Tregs or TIL cell therapies TAMPA, Fla., Oct. 5, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that the United States Patent and Trademark Office has issued U.S. Patent No.
Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), on track to initiate in the fourth quarter of 2026
Three income buckets and eight holdings can close the gap between your current savings and a five-figure monthly paycheck, but the math behind each yield level reveals a trade-off most investors never think to calculate.
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced results from Part C of the Phase 1/2 RAINFOLâ¢-01 trial evaluating rinatabart sesutecan (Rina-S), an inv
Most retirees lean on Social Security as their primary income, but a dividend portfolio sized correctly could double that monthly check entirely. The catch is that choosing the wrong yield tier could cost you hundreds of thousands of dollars or quietly erode your principal over time.
Simon Property Group and Agree Realty offer 4%+ yields and double-digit total return potential amid sector pullbacks from rising bond yields. SPG's A-rated balance sheet, accelerating NOI, and raised FFO guidance position it well despite $2B in 2024 debt maturities and volatile rates. ADC's investment-grade tenant focus, long-term ground leases, low leverage, and insider buying support its resilience and 4.7% well-covered monthly yield.
Summit Therapeutics Inc. (Nasdaq: SMMT) today announced a clinical trial collaboration agreement with Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE:
The 10-year Treasury yield just hit a year-long high and dragged every one of these net lease REITs down with it, but falling share prices and failing dividends are not the same thing, and the difference matters more right now
Montreal, Quebec--(Newsfile Corp. - October 1, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® platform, is pleased to announce its participation in the 17th World ADC San Diego, taking place October 12-15, 2026, in San Diego, California. World ADC San Diego is a leading global forum dedicated to antibody-drug conjugates ("ADCs"), bringing together leaders from pharmaceutical and biotechnology companies, emerging innovators, academia and the clinical community to exchange scientific insights, foster collaboration and advance the development of next-generation ADCs.